Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from The Pitfalls of HIV-1 DNA Resistance Genotyping: What it can and cannot tell us. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance
10.1093/cid/ciaf161 · 2025 · External reference
Unresolved reference
External reference
Clearance of archived integrase strand transfer inhibitors resistance mutations in people with virologically suppressed HIV infection
10.1093/jacamr/dlae194 · 2024 · External reference
Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected Patients
10.1093/infdis/jiab413 · 2022 · External reference
The RT M184V resistance mutation clearance in the reservoir is mainly related to CD4 nadir and viral load zenith independently of therapeutic regimen type
10.1093/jac/dkae164 · 2024 · External reference
Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial
10.1016/s1473-3099(24)00289-5 · 2024 · External reference
Randomized Trial of Long-Acting Cabotegravir and Rilpivirine in Africa (CARES): Week 96 Results
2025 · External reference
Kinetics of Non-nucleoside Reverse Transcriptase Inhibitor Resistance-associated Mutations in HIV-1 Proviral Cellular Reservoirs in Non-nucleoside Reverse Transcriptase Inhibitor-experienced Persons
10.1093/cid/ciaf430 · 2026 · External reference
Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients
10.1089/apc.2019.0198 · 2020 · External reference
Use of genotypic HIV DNA testing: a DELPHI-type consensus
10.1093/jac/dkae007 · 2024 · External reference
No virological failure in patients living with HIV with past NNRTI resistance-associated mutations switched to doravirine-containing regimens
10.1093/jac/dkae481 · 2025 · External reference
Learning From Full Characterization of HIV Proviruses in People Receiving Long-Acting Cabotegravir/Rilpivirine With a History of Replication on the Antiretroviral Classes
2025 · External reference
Fully injectable antiretroviral multitherapy to overcome decades of virological failure in three women with hiv-1 and non-adherent to oral drugs
10.1016/j.ijantimicag.2024.107254 · 2024 · External reference
Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons With Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results of a Single-Arm, Open-Label, Multicenter, Phase IIa Clinical Trial
10.1093/cid/ciaf100 · 2025 · External reference
Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants
10.1016/j.celrep.2017.09.081 · 2017 · External reference
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure
10.1016/j.cell.2013.09.020 · 2013 · External reference
In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control
10.1128/spectrum.03267-22 · 2023 · External reference
Unresolved reference
External reference
Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review
10.3390/v15091932 · 2023 · External reference
Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals
10.1016/j.jcv.2023.105551 · 2023 · External reference
Defective HIV-1 quasispecies in the form of multiply drug-resistant proviral DNA within cells can be rescued by superinfection with different subtype variants of HIV-1 and by HIV-2 and SIV
10.1093/jac/dkt326 · 2014 · External reference
Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants
10.1086/606117 · 2009 · External reference
Superinfection promotes replication and diversification of defective HIV-1 proviruses in people with non-suppressible viraemia
10.1038/s41564-025-02135-z · 2025 · External reference
Unresolved reference
External reference
Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing
10.1093/jac/dkt316 · 2014 · External reference
Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy
10.1172/jci124291 · 2019 · External reference
Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses
10.1016/j.cell.2021.12.011 · 2022 · External reference
Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection
10.1084/jem.20241091 · 2024 · External reference
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
10.1128/jvi.01920-18 · 2019 · External reference
Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1
10.1073/pnas.2020617117 · 2020 · External reference
Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption
10.1126/scitranslmed.abd8179 · 2021 · External reference
Next-generation sequencing and drug resistance mutations of HIV-1 subtypes in people living with HIV in Sicily, Italy, 2021-2023
10.1016/j.jgar.2024.12.015 · 2024 · External reference
Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications
10.1128/cmr.00015-16 · 2016 · External reference
Kinetics of non-nucleoside reverse transcriptase inhibitor resistance-associated mutations in HIV-1 proviral cellular reservoirs in NNRTI-experienced persons
2025 · External reference
The multifaceted nature of HIV tissue reservoirs
10.1097/coh.0000000000000851 · 2024 · External reference
Eliminating HIV reservoirs for a cure: the issue is in the tissue
10.1097/coh.0000000000000688 · 2021 · External reference
HIV persists throughout deep tissues with repopulation from multiple anatomical sources
10.1172/jci134815 · 2020 · External reference
Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ART
10.1016/j.celrep.2023.113053 · 2023 · External reference
HIV Variability in the Liver and Evidence of Possible Compartmentalization
10.1089/aid.2010.0329 · 2011 · External reference
Identification of HIV-1 genitourinary tract compartmentalization by analyzing the env gene sequences in urine
10.1097/qad.0000000000000757 · 2015 · External reference
Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4+ T Cell Subsets during Long-Term Combination Antiretroviral Therapy
10.1128/jvi.01786-19 · 2020 · External reference
HIV Diversity and Genetic Compartmentalization in Blood and Testes during Suppressive Antiretroviral Therapy
10.1128/jvi.00755-19 · 2019 · External reference
Compartmentalization and Clonal Amplification of HIV-1 in the Male Genital Tract Characterized Using Next-Generation Sequencing
10.1128/jvi.00229-20 · 2020 · External reference
Compartmentalized HIV-1 reservoir in intestinal monocytes/macrophages on antiretroviral therapy
2024 · External reference
HIV persistence in tissues on dolutegravir-based therapy is not associated with resistance mutations to dolutegravir
10.1038/s43856-026-01405-z · 2026 · External reference
Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression
10.1093/jac/dkv395 · 2016 · External reference
Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing
10.1073/pnas.2117630119 · 2022 · External reference
Clonal Expansion of Infected CD4+ T Cells in People Living with HIV
10.3390/v13102078 · 2021 · External reference
Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART
10.1038/s41467-020-17898-8 · 2020 · External reference
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
10.1038/nm.1972 · 2009 · External reference
The multifaceted nature of HIV latency
10.1172/jci136227 · 2020 · External reference
The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies
10.1016/j.chom.2020.03.014 · 2020 · External reference
Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane
2018 · External reference
